Comparison of the Mucosal Immune Response in Dogs Vaccinated with Either an Intranasal Avirulent Live Culture or a Subcutaneous Antigen Extract Vaccine of Bordetella bronchiseptica

Healthy dogs with low antibody titer to Bordetella bronchiseptica were vaccinated intranasally with an avirulent live vaccine, subcutaneously with an antigen extract vaccine, or subcutaneously and intranasally with a placebo. Intranasally vaccinated dogs developed B. bronchiseptica–specific IgA titers in nasal secretions that remained at high levels until the end of the study; dogs vaccinated subcutaneously with the antigen extract or placebo did not develop measurable antigen-specific IgA titers in nasal secretions. Dogs were challenged with virulent live B. bronchiseptica 63 days after vaccination. Intranasally vaccinated dogs had significantly lower cough scores (P ≤ .0058) and shed significantly fewer challenge organisms (P < .0001) than dogs in either of the other groups. Cough scores of subcutaneously vaccinated dogs were not significantly different from placebo-vaccinated dogs. Comparison of the Mucosal Immune Response in Dogs Vaccinated with Either an Intranasal Avirulent Live Culture or a Subcutaneous Antigen Extract Vaccine of Bordetella bronchiseptica*